Joseph Fredi Archives
Trial to test aortic valve technique in lower-risk patients
Oct. 27, 2016—In 2011, doctors at the Vanderbilt Heart and Vascular Institute performed the state’s first transcatheter valve-replacement (TAVR) procedure for high-risk patients suffering from aortic stenosis, the most common valvular heart disease in the United States.
Vanderbilt Heart to participate in CoreValve clinical trial
Apr. 18, 2011—Vanderbilt Heart will soon begin testing the safety of a novel, non-surgical approach to treating aortic stenosis, a common heart problem caused by an abnormal narrowing of the heart's aortic valve.